Guided Therapeutics Receives $100,000 from SMI’s Investment Partners to Continue Commercialization Process of LuViva in China
Thursday, May 29th, 2025
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received a $100,000 payment from Shandong Yaohua Medical Instrument Corporation (SMI) via its investment partners to assist in commercializing LuViva in China. The $100,000 payment is the first of several such payments that provide for an extension of GTHP’s agreement with SMI to commercialize LuViva in China upon regulatory approval in China by September of this year. A portion of the proceeds will be used to supply SMI and its partner distributors in China with electronic components used in certain LuViva accessories.
